An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer.

Feins, Steven; Kong, Weimin; Williams, Erik F; Milone, Michael C; Fraietta, Joseph A

Feins, Steven; Kong, Weimin; Williams, Erik F; Milone, Michael C; Fraietta, Joseph A.

Afiliação

Feins S; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Kong W; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Williams EF; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
Milone MC; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Fraietta JA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Am J Hematol ; 94(S1): S3-S9, 2019 05.

Article em En | MEDLINE | ID: mdl-30680780

Assuntos

Imunoterapia Adotiva/métodos; Neoplasias/terapia; Receptores de Antígenos Quiméricos/uso terapêutico; Antígenos CD19/imunologia; Antígenos CD19/uso terapêutico; Biomarcadores; Humanos; Tolerância Imunológica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Receptores de Antígenos Quiméricos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google